Clincosm LogoSign in Get a demo

Delivering Treatment in DUI Programs to Reduce Alcohol-Related Disparities

Sponsor
RAND (Other)
Overall Status
Completed
CT.gov ID
NCT02588703
Collaborator
(none)
351
Enrollment
2
Arms
54
Actual Duration (Months)

Study Details

Study Description

Brief Summary

The current study evaluates the efficacy of Cognitive Behavioral Therapy (CBT) in DUI programs for individuals with a first-time offense. Investigators will utilize a two-group randomized design where individuals enrolled in a DUI program with a first-time conviction will be randomized to Cognitive Behavioral Therapy (CBT; n=150) or Usual Care (UC; n=150). Participants will be assessed at baseline, immediately post-treatment, and 6-months post-treatment. Recidivism data will also be collected using administrative data two years post-treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy
  • Behavioral: Usual Care
 Phase 2

Detailed Description

Enormous unmet needs for alcohol treatment exist among individuals convicted of driving under the influence (DUI) since up to 43% recidivate and 67% meet criteria for alcohol dependence. Investigators will test whether delivering a cognitive behavioral treatment (CBT) for alcohol use disorders (AUDs) as part of a mandated DUI program improves health outcomes, and reduces alcohol use, alcohol-related problems and injuries, and DUI recidivism compared to usual care. The study has the potential to promote the public welfare by providing treatment to individuals with a DUI conviction, while focusing on Latinos, who are disproportionately less likely to access treatment and more likely to be arrested for a DUI, to have higher rates of recidivism, and to die in alcohol-related crashes than their white counterparts. The study is innovative because it would be the first to address effectiveness of treatment for AUDs embedded within a DUI program. Investigators will conduct a randomized trial of a 9-session group-based CBT (n=150) as compared to group-based usual care (UC; n=150) immediately after and 6 months after the end of treatment. Short-term outcomes include alcohol use (rates of heavy drinking, percent days abstinent), alcohol use-related self-efficacy, and intent to drink and drive. Investigators will also examine whether race/ethnicity, gender, acculturation, and alcohol situational norms predict our primary treatment outcomes (rates of heavy drinking, percent days abstinent) and DUI recidivism (alcohol-related violations).

Study Design

Study Type:
Interventional
Actual Enrollment :
351 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
RCTRCT
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Delivering Treatment in DUI Programs to Reduce Alcohol-Related Disparities
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Jul 1, 2018
Actual Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Behavioral Therapy

9-session 2-hour group cognitive behavioral therapy

Behavioral: Cognitive Behavioral Therapy
Coping Skills Treatment
Other Names:
  • CBT

    		•
    Active Comparator: Usual Care

    9-session 2-hour group counseling

    Behavioral: Usual Care
    Existing DUI program group counseling

    Outcome Measures

    Primary Outcome Measures

    1. heavy drinking (Survey) [6 months]

      frequency of 5 drinks per day for men and 4 drinks per day for women

    Secondary Outcome Measures

    1. DUI Behaviors and Attitudes (Survey) [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • meets criteria for at-risk drinking,

    • 21 years+,

    • English speaking,

    • current client in 3-month DUI program

    Exclusion Criteria:

    • under 21,

    • does not speak English,

    • does not meet criteria for at-risk drinking

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • RAND

    Investigators

    • Principal Investigator: Karen C Osilla, PhD, RAND

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karen Osilla, Senior Behavioral Scientist, RAND
    ClinicalTrials.gov Identifier:
    NCT02588703
    Other Study ID Numbers:
    • R01MD007762
    First Posted:
    Oct 28, 2015
    Last Update Posted:
    Apr 10, 2020
    Last Verified:
    Apr 1, 2020
    Additional relevant MeSH terms:
    Alcoholism

    Study Results

    No Results Posted as of Apr 10, 2020